Great Lakes NeuroTechnologies, a Cleveland-area company that promised more focus on DBS treatments as well as new products this year, has expanded its intellectual property in that area. The patent covers a wearable apparatus that positions an array of electrodes on the surface of the scalp and provides low-dose stimulation to the brain using […]
Cleveland-area patient monitoring company Great Lakes NeuroTechnologies is using the momentum it’s built in the clinical trials market to drive penetration of its device/software technology for assessing Parkinson’s disease symptoms in to other markets this year. The company’s U.S. Food and Drug Administration-cleared Kinesia technology platform is designed to give clinicians a quantitative way to […]
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Great Lakes NeuroTechnologies has been awarded a new patent for its technology that quantifies the severity of movement disorders in Parkinson’s disease patients. Great Lakes’ Kinesia movement disorder assessment technology uses a ring-like sensor worn on a patient’s finger to measure motor symptoms and wirelessly transmit data to physicians on the severity of a patient’s […]
Great Lakes NeuroTechnologies has secured $4.5 million in new grant funding that the company will use in part to further develop its Parkinson’s disease monitoring technology. The funding comes through the National Institutes of Health’s Small Business Innovation Research (SBIR) program, according to a statement from Valley View, Ohio-based Great Lakes. The larger grant, about […]
A neurotechnology company has launched a multisite study to assess its technology in the continuous monitoring of patients with movement disorders, such as those associated with Parkinson’s disease. Great Lakes NeuroTechnologies‘ will follow 60 patients with essential tremor, a type of involuntary shaking of the body, as they conduct their daily lives in their homes, […]
A neurotechnology company is planning a clinical study aimed at helping it enter the deep brain stimulation market for Parkinson’s disease patients. Cleveland-based Great Lakes NeuroTechnologies is aiming to help surgeons and neurologists fine-tune deep brain stimulation (DBS) systems after they’ve been implanted in Parkinson’s patients. DBS involves implanting an electrode in the brain to […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Great Lakes NeuroTechnologies has received two federal grants totaling about $2 million to further develop its technologies for home-based monitoring of patients suffering from movement disorders, such as Parkinson’s disease. The largest of the two grants from the National Institutes of Health, $1.7 million, will go toward the development of a portable essential tremor monitor […]
A Cleveland startup has developed a web-based system that assesses the severity of Parkinson’s disease symptoms and helps doctors better tailor medications to people with Parkinson’s. Great Lakes NeuroTechnologies has been around since 2006 as a division of Cleveland Medical Devices, but was spun off earlier this year as a stand-alone company to focus on […]